Patents by Inventor Myles Honicker

Myles Honicker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11399763
    Abstract: Conduction velocity information for a cardiac region can be used to map the cardiac muscle fiber orientation of that region. In particular, for a plurality of locations within the cardiac region, a relationship between a local conduction velocity, a maximum local conduction velocity within the region, and a minimum local conduction velocity within the region is used to determine the cardiac muscle fiber orientation at the respective location. Even more particularly, when the local conduction velocity at the respective location equals the maximum local conduction velocity, the cardiac muscle fiber orientation is parallel to a direction of a conduction velocity vector at the respective location, and when the local conduction velocity at the respective location equals the minimum local conduction velocity, the cardiac muscle fiber orientation is perpendicular to a direction of a conduction velocity vector at the respective location.
    Type: Grant
    Filed: January 3, 2019
    Date of Patent: August 2, 2022
    Assignee: St. Jude Medical, Cardiology Division, Inc.
    Inventor: Myles Honicker
  • Patent number: 11071486
    Abstract: Cardiac activation timing is mapped using a catheter-mounted roving electrode instead of a fixed (e.g., coronary sinus) electrode. The roving electrode is used to measure an initial electrophysiological signal at an initial cardiac location as a reference signal, which is defined as a reference signal. Local activation time(s) for other cardiac location(s), also measured using the catheter-mounted roving electrode, are determined relative to the reference signal. The stability of the reference signal can be monitored, such as by comparing activation rates or cycle lengths between an instantaneously-measured electrophysiological signal and the initial electrophysiological signal. Smaller differences between the two (e.g., less than about 5%) can be compensated for, while larger differences can result in redefining the reference signal.
    Type: Grant
    Filed: May 9, 2019
    Date of Patent: July 27, 2021
    Assignee: St. Jude Medical, Cardiology Division, Inc.
    Inventor: Myles Honicker
  • Publication number: 20210052178
    Abstract: Conduction velocity information for a cardiac region can be used to map the cardiac muscle fiber orientation of that region. In particular, for a plurality of locations within the cardiac region, a relationship between a local conduction velocity, a maximum local conduction velocity within the region, and a minimum local conduction velocity within the region is used to determine the cardiac muscle fiber orientation at the respective location. Even more particularly, when the local conduction velocity at the respective location equals the maximum local conduction velocity, the cardiac muscle fiber orientation is parallel to a direction of a conduction velocity vector at the respective location, and when the local conduction velocity at the respective location equals the minimum local conduction velocity, the cardiac muscle fiber orientation is perpendicular to a direction of a conduction velocity vector at the respective location.
    Type: Application
    Filed: January 3, 2019
    Publication date: February 25, 2021
    Inventor: Myles Honicker
  • Publication number: 20190365262
    Abstract: Cardiac activation timing is mapped using a catheter-mounted roving electrode instead of a fixed (e.g., coronary sinus) electrode. The roving electrode is used to measure an initial electrophysiological signal at an initial cardiac location as a reference signal, which is defined as a reference signal. Local activation time(s) for other cardiac location(s), also measured using the catheter-mounted roving electrode, are determined relative to the reference signal. The stability of the reference signal can be monitored, such as by comparing activation rates or cycle lengths between an instantaneously-measured electrophysiological signal and the initial electrophysiological signal. Smaller differences between the two (e.g., less than about 5%) can be compensated for, while larger differences can result in redefining the reference signal.
    Type: Application
    Filed: May 9, 2019
    Publication date: December 5, 2019
    Inventor: Myles Honicker